Search Results - "Kim, Ye Seon"
-
1
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
Published in Scientific reports (04-10-2021)“…The emergence of resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) with activating…”
Get full text
Journal Article -
2
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Published in Experimental & molecular medicine (09-08-2019)“…Programmed cell death protein-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway blockade is a promising new cancer therapy. Although PD-1/PD-L1 treatment…”
Get full text
Journal Article -
3
MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation
Published in Cancer research (Chicago, Ill.) (2014)“…In non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations, acquired resistance to EGFR-tyrosine kinase inhibitors (EGFR-TKI)…”
Get full text
Journal Article -
4
Enhanced Glycolysis Supports Cell Survival in EGFR-Mutant Lung Adenocarcinoma by Inhibiting Autophagy-Mediated EGFR Degradation
Published in Cancer research (Chicago, Ill.) (15-08-2018)“…Oncogenic EGFR is essential for the development and growth of non-small cell lung cancer (NSCLC), but the precise roles of EGFR in lung cancer metabolism…”
Get full text
Journal Article -
5
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
Published in Targeted oncology (01-04-2020)“…Background Immunotherapy with immune checkpoint inhibitors for non-small cell lung cancer (NSCLC) has emerged as an important treatment option. Although…”
Get full text
Journal Article -
6
Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
Published in Oncotarget (19-04-2016)“…Mutant-selective, 3rd-generation EGFR-TKIs were recently developed to control lung cancer cells harboring T790M-mediated resistance. However, the development…”
Get full text
Journal Article -
7
AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells
Published in PloS one (17-03-2015)“…The activation of bypass signals, such as MET and AXL, has been identified as a possible mechanism of EGFR-TKI resistance. Because various oncoproteins depend…”
Get full text
Journal Article -
8
Ethyl pyruvate stabilizes hypoxia-inducible factor 1 alpha via stimulation of the TCA cycle
Published in Cancer letters (28-09-2010)“…Abstract Ethyl pyruvate is a simple derivative of the endogenous metabolite pyruvate. Pyruvate is the starting substrate for the tricarboxylic acid (TCA) cycle…”
Get full text
Journal Article -
9
Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis
Published in Neuroscience letters (09-01-2009)“…1-Methyl-4-phenylpyridinium ion (MPP +) has been shown to selectively inhibit mitochondrial function and induce a parkinsonism-like syndrome. MPP + stimulates…”
Get full text
Journal Article -
10
Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer
Published in Targeted oncology (01-06-2018)“…Background Despite remarkable activity in epidermal growth factor receptor (EGFR)-mutant lung cancer patients, the clinical efficacy of EGFR tyrosine kinase…”
Get full text
Journal Article -
11
Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1
Published in Cancer letters (08-04-2009)“…Abstract Okadaic acid, a potent tumor promoter and an inhibitor of protein phosphatase 1 and 2A, has also been characterized as an angiogenic inducer in the…”
Get full text
Journal Article -
12
Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor
Published in Tuberculosis and respiratory diseases (01-09-2013)“…Small cell lung cancer (SCLC) transformation during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in lung cancer has been…”
Get full text
Journal Article -
13
Isovaleric acid ameliorates ovariectomy‐induced osteoporosis by inhibiting osteoclast differentiation
Published in Journal of cellular and molecular medicine (01-05-2021)“…Osteoclasts (OCs) play important roles in bone remodelling and contribute to bone loss by increasing bone resorption activity. Excessively activated OCs cause…”
Get full text
Journal Article -
14
WKYMVm ameliorates obesity by improving lipid metabolism and leptin signalling
Published in Journal of cellular and molecular medicine (01-09-2023)“…Abstract Obesity is a metabolic disorder that results from an imbalance of energy intake and consumption. As low‐grade chronic inflammation caused by obesity…”
Get full text
Journal Article -
15
Therapeutic effects of a phospholipase D1 inhibitor against polymicrobial sepsis
Published in The Journal of immunology (1950) (01-05-2019)“…Abstract In this study, we found that a phospholipase D1-selective inhibitor (VU0155069), significantly increased survival rate against cecal ligation and…”
Get full text
Journal Article -
16
CD200Rhigh neutrophils with dysfunctional autophagy establish systemic immunosuppression by increasing regulatory T cells
Published in Cellular & molecular immunology (01-04-2024)“…Distinct neutrophil populations arise during certain pathological conditions. The generation of dysfunctional neutrophils during sepsis and their contribution…”
Get full text
Journal Article -
17
Unique characteristics of lung-resident neutrophils are maintained by PGE2/PKA/Tgm2-mediated signaling
Published in Blood (25-08-2022)“…Lung-resident neutrophils need to be tightly regulated to avoid degranulation- and cytokine-associated damage to fragile alveolar structures that can lead to…”
Get full text
Journal Article -
18
IM156, a new AMPK activator, protects against polymicrobial sepsis
Published in Journal of cellular and molecular medicine (01-06-2022)“…IM156, a novel biguanide with higher potency of AMP‐activated protein kinase activation than metformin, has inhibitory activity against angiogenesis and…”
Get full text
Journal Article -
19
AKT/mTOR down-regulation by CX-4945, a CK2 inhibitor, promotes apoptosis in chemorefractory non-small cell lung cancer cells
Published in Anticancer research (01-03-2015)“…The response to chemotherapeutic drugs in non-small cell lung cancer (NSCLC) is unsatisfactory, leading to poor outcomes. This study the aimed to investigates…”
Get full text
Journal Article -
20
VU0155069 inhibits inflammasome activation independent of phospholipase D1 activity
Published in Scientific reports (04-10-2019)“…The inflammasome is a specialized multiprotein oligomer that regulates IL-1β production. Although regulation of the inflammasome is related to crucial…”
Get full text
Journal Article